<VariationArchive VariationID="2752602" VariationName="NM_000320.3(QDPR):c.523del (p.Ala175fs)" VariationType="Deletion" Accession="VCV002752602" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2024-02-14" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2913343" VariationID="2752602">
      <GeneList>
        <Gene Symbol="QDPR" FullName="quinoid dihydropteridine reductase" GeneID="5860" HGNC_ID="HGNC:9752" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>4p15.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="17486395" stop="17512090" display_start="17486395" display_stop="17512090" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="17488015" stop="17513856" display_start="17488015" display_stop="17513856" Strand="-" />
          </Location>
          <OMIM>612676</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000320.3(QDPR):c.523del (p.Ala175fs)</Name>
      <CanonicalSPDI>NC_000004.12:17492253:CCCC:CCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>4p15.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="17492254" stop="17492254" display_start="17492254" display_stop="17492254" variantLength="1" positionVCF="17492253" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="17493877" stop="17493877" display_start="17493877" display_stop="17493877" variantLength="1" positionVCF="17493876" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>A144fs</ProteinChange>
      <ProteinChange>A175fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.11" sequenceAccession="NC_000004" sequenceVersion="11" change="g.17493880del" Assembly="GRCh37">
            <Expression>NC_000004.11:g.17493880del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.12" sequenceAccession="NC_000004" sequenceVersion="12" change="g.17492257del" Assembly="GRCh38">
            <Expression>NC_000004.12:g.17492257del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008763.1" sequenceAccession="NG_008763" sequenceVersion="1" change="g.24981del">
            <Expression>NG_008763.1:g.24981del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000320.3" sequenceAccession="NM_000320" sequenceVersion="3" change="c.523del" MANESelect="true">
            <Expression>NM_000320.3:c.523del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000311.2" sequenceAccession="NP_000311" sequenceVersion="2" change="p.Ala175fs">
            <Expression>NP_000311.2:p.Ala175fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001306140.2" sequenceAccession="NM_001306140" sequenceVersion="2" change="c.430del">
            <Expression>NM_001306140.2:c.430del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001293069.1" sequenceAccession="NP_001293069" sequenceVersion="1" change="p.Ala144fs">
            <Expression>NP_001293069.1:p.Ala144fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000320.3(QDPR):c.523del (p.Ala175fs) AND Dihydropteridine reductase deficiency" Accession="RCV003495729" Version="1">
        <ClassifiedConditionList TraitSetID="135">
          <ClassifiedCondition DB="MedGen" ID="C0268465">Dihydropteridine reductase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-31" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-14" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11153907</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7627180</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="135" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2367" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Phenylketonuria II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPERPHENYLALANINEMIA, TETRAHYDROBIOPTERIN-DEFICIENT, DUE TO DHPR DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="261630" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperphenylalaninemia due to dihydropteridine reductase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperphenylalaninemia, BH-4-deficient, C</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Phenylketonuria type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Dihydropteridine reductase deficiency</ElementValue>
                <XRef ID="Phenylketonuria+type+2/5716" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009862" DB="MONDO" />
                <XRef ID="58256000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Quinoid dihydropteridine reductase deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HPABH4C</ElementValue>
                <XRef Type="MIM" ID="261630" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4319" />
                <XRef ID="4319" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Phenylalanine.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated Phenylalanine, Phenylalanine hydroxylase deficiency (PAH), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Phenylalanine-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, PAH deficiency: Elevated Phenylalanine, 2022</CitationText>
              </Citation>
              <XRef ID="226" DB="Orphanet" />
              <XRef ID="238583" DB="Orphanet" />
              <XRef ID="C0268465" DB="MedGen" />
              <XRef ID="MONDO:0009862" DB="MONDO" />
              <XRef Type="MIM" ID="261630" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8001615" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="23526108|MedGen:C0268465" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004317553" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">7627180</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11153907</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with QDPR-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ala175Glnfs*15) in the QDPR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in QDPR are known to be pathogenic (PMID: 7627180, 11153907).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="QDPR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000004.11:g.17493877del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268465" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8001615" TraitType="Disease" MappingType="XRef" MappingValue="C0268465" MappingRef="MedGen">
        <MedGen CUI="C0268465" Name="Dihydropteridine reductase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

